Hao Sun

TitlePostdoctoral Scholar
InstitutionUniversity of California San Diego
Address9500 Gilman Drive #0723
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Sun H, Lagarrigue F, Gingras AR, Fan Z, Ley K, Ginsberg MH. Transmission of integrin ß7 transmembrane domain topology enables gut lymphoid tissue development. J Cell Biol. 2018 Apr 02; 217(4):1453-1465. PMID: 29535192.
      View in: PubMed
    2. Sun H, Chan S, Yenson P, Jackson S. Inhibitor Risk Stratification and Individualized Treatment in Patients With Nonsevere Hemophilia A: A Single-Institution Practice Audit. Clin Appl Thromb Hemost. 2018 Mar; 24(2):303-309. PMID: 29108420.
      View in: PubMed
    3. Sun H, McIntosh KA, Squire SJ, Yang M, Bartholomew C, Gue DS, Camp PG, Jackson SC. Patient powered prophylaxis: A 12-month study of individualized prophylaxis in adults with severe haemophilia A. Haemophilia. 2017 Nov; 23(6):877-883. PMID: 28851133.
      View in: PubMed
    4. Sun H, Atenafu EG, Tsang R, Kukreti V, Marras TK, Crump M, Kuruvilla J. Bleomycin pulmonary toxicity does not adversely affect the outcome of patients with Hodgkin lymphoma. Leuk Lymphoma. 2017 Nov; 58(11):2607-2614. PMID: 28504035.
      View in: PubMed
    5. Petrich AM, Gandhi M, Jovanovic B, Castillo JJ, Rajguru S, Yang DT, Shah KA, Whyman JD, Lansigan F, Hernandez-Ilizaliturri FJ, Lee LX, Barta SK, Melinamani S, Karmali R, Adeimy C, Smith S, Dalal N, Nabhan C, Peace D, Vose J, Evens AM, Shah N, Fenske TS, Zelenetz AD, Landsburg DJ, Howlett C, Mato A, Jaglal M, Chavez JC, Tsai JP, Reddy N, Li S, Handler C, Flowers CR, Cohen JB, Blum KA, Song K, Sun H, Press O, Cassaday R, Jaso J, Medeiros LJ, Sohani AR, Abramson JS. Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis. Blood. 2014 Oct 09; 124(15):2354-61. PMID: 25161267.
      View in: PubMed
    6. Sun H, Atenafu EG, Yeboah E, Reece DE, Trudel S, Kukreti V, Masih-Khan E, Winter A, Chen C. Intermittent granulocyte colony-stimulating factor for neutropenia management in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone. Leuk Lymphoma. 2015 Feb; 56(2):407-14. PMID: 24738975.
      View in: PubMed